Drug profile · INN
vardenafil hydrochloride
VARDENAFIL HYDROCHLORIDE
vardenafil hydrochloride (VARDENAFIL HYDROCHLORIDE) is a phosphodiesterase 5a inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — vardenafil hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
vardenafil hydrochloride (VARDENAFIL HYDROCHLORIDE) is a phosphodiesterase 5a inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Phosphodiesterase 5A inhibitor
Primary target: cGMP-specific 3',5'-cyclic phosphodiesterase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is vardenafil hydrochloride?
vardenafil hydrochloride (VARDENAFIL HYDROCHLORIDE) is a phosphodiesterase 5a inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vardenafil hydrochloride?
VARDENAFIL HYDROCHLORIDE is a marketed brand name for vardenafil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vardenafil hydrochloride?
vardenafil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.